In associated information, Director Mark Grabowski offered 5,175,000 shares of the agency’s inventory in a transaction that occurred on Monday, April eleventh. The shares have been offered at a median worth of $20.00, for a complete transaction of $103,500,000.00. Following the transaction, the director now owns 6,122 shares of the corporate’s inventory, valued at $122,440. The sale was disclosed in a authorized submitting with the SEC, which is out there via this hyperlink. Firm insiders personal 69.33% of the corporate’s inventory.
A number of brokerages have lately issued experiences on XPOF. Evercore ISI started protection on shares of Xponential Health in a analysis notice on Monday, March 14th. They issued an “outperform” score and a $34.00 worth goal on the inventory. Raymond James lowered their worth goal on shares of Xponential Health from $28.00 to $27.00 and set a “strong-buy” score on the inventory in a analysis notice on Friday, March 4th. Lastly, Robert W. Baird lifted their worth goal on shares of Xponential Health from $26.00 to $28.00 in a analysis notice on Monday, March 14th. 9 analysts have rated the inventory with a purchase score and one has given a robust purchase score to the corporate’s inventory. In keeping with knowledge from MarketBeat.com, the inventory presently has a median score of “Purchase” and a consensus goal worth of $24.83.
Shares of XPOF opened at $12.48 on Monday. Xponential Health, Inc. has a one 12 months low of $9.87 and a one 12 months excessive of $26.90. The corporate has a 50-day transferring common of $17.48 and a two-hundred day transferring common of $19.06. The inventory has a market cap of $609.21 million and a price-to-earnings ratio of -2.67.
Comments
0 comments